Beximco Pharmaceuticals announced it would start to export hypertensive drug, Carvedilol to the U.S.A. It would be the first Bangladeshi company to do so. It is a big achievement for the country as a whole. Bangladesh’s ever growing drug industry, after meeting local demand, exports to a number of countries including.
Bangladesh can make generic drugs without any intellectual property rights until 2O33 as a Least Developed Country.
Finance Minister Abul Maal Abdul Muhith was present in the launching program. He said "Beximco Pharmaceuticals achieved glory for us." Then he continued "we must celebrate the glory”. US Ambassador Marcia Bernicat was also there in the program. She said “a testament to Beximco’s hard work as well as the quality of their products. I am especially proud that US consumers will now be able to take a life-saving drug and see ‘made in Bangladesh’ on the bottle.” She said receiving US FDA approval was a “long and rigorous” process. Health Minister Mohammed Nasim also congratulated the company.
Beximco Group Vice Chairman Mr. Salman F Rahman said, "Today is a significant milestone for Beximco Pharma. As we deliver our first shipment of Carvedilol to the US market, we begin a new era for the pharmaceutical industry in Bangladesh. We believe our continued focus on building and strengthening the Group's presence in Western markets will cement Bangladesh's position as a major exporting country."
Beximco Pharmaceuticals is the largest exporter of pharmaceuticals in Bangladesh. It has won National Export Trophy (Gold) a record five times. The company currently has a global footprint in more than 50 countries and has been accredited by a number of global regulatory authorities. These include, apart from the FDA, the AGES (EU), TGA Australia, Health Canada, the Gulf Cooperation Council (GCC) and the Tanzanian Food and Drugs Authority (TFDA).